WO2008078729A1 - 溶出性改善方法 - Google Patents
溶出性改善方法 Download PDFInfo
- Publication number
- WO2008078729A1 WO2008078729A1 PCT/JP2007/074784 JP2007074784W WO2008078729A1 WO 2008078729 A1 WO2008078729 A1 WO 2008078729A1 JP 2007074784 W JP2007074784 W JP 2007074784W WO 2008078729 A1 WO2008078729 A1 WO 2008078729A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dissolution property
- improving dissolution
- azelnidipine
- olmesartan medoxomil
- improving
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008551107A JP5241512B2 (ja) | 2006-12-26 | 2007-12-25 | 溶出性改善方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006349474 | 2006-12-26 | ||
JP2006-349474 | 2006-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008078729A1 true WO2008078729A1 (ja) | 2008-07-03 |
Family
ID=39562518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/074784 WO2008078729A1 (ja) | 2006-12-26 | 2007-12-25 | 溶出性改善方法 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5241512B2 (ko) |
KR (1) | KR20090094285A (ko) |
TW (1) | TWI488658B (ko) |
WO (1) | WO2008078729A1 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010107081A1 (ja) * | 2009-03-19 | 2010-09-23 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
JP2011225537A (ja) * | 2010-03-31 | 2011-11-10 | Daiichi Sankyo Co Ltd | 固形製剤の製造方法 |
JP2014224099A (ja) * | 2013-04-15 | 2014-12-04 | 株式会社三和化学研究所 | オルメサルタンメドキソミルを含有する医薬組成物 |
JP2015511635A (ja) * | 2012-03-30 | 2015-04-20 | デウン ファーマシューティカル カンパニー リミテッド | オルメサルタンメドキソミルとロスバスタチンまたはその塩とを含む医薬組成物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004067003A1 (ja) * | 2003-01-31 | 2004-08-12 | Sankyo Company, Limited | 動脈硬化及び高血圧症の予防及び治療のための医薬 |
JP2006298764A (ja) * | 2005-04-15 | 2006-11-02 | Sankyo Co Ltd | 高血圧症治療に有用な複合体 |
WO2007001067A2 (en) * | 2005-06-27 | 2007-01-04 | Daiichi Sankyo Company, Limited | Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1100469T3 (da) * | 1998-07-28 | 2005-04-18 | Takeda Pharmaceutical | Hurtigt henfaldende fast præparat |
US20060034913A1 (en) * | 2004-08-13 | 2006-02-16 | James Gaede | Multiplex drug delivery device |
PT1814527E (pt) * | 2004-11-05 | 2014-01-16 | Boehringer Ingelheim Int | Comprimido de bicamada compreendendo telmisartan e amlodipina |
JP5063370B2 (ja) * | 2005-06-27 | 2012-10-31 | 第一三共株式会社 | 湿式造粒製薬の調製方法 |
JP5148296B2 (ja) * | 2005-06-27 | 2013-02-20 | 第一三共株式会社 | アンジオテンシンii受容体拮抗剤及びカルシウム拮抗剤含有医薬組成物 |
-
2007
- 2007-12-24 TW TW096149678A patent/TWI488658B/zh not_active IP Right Cessation
- 2007-12-25 JP JP2008551107A patent/JP5241512B2/ja active Active
- 2007-12-25 WO PCT/JP2007/074784 patent/WO2008078729A1/ja active Application Filing
- 2007-12-25 KR KR1020097012652A patent/KR20090094285A/ko not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004067003A1 (ja) * | 2003-01-31 | 2004-08-12 | Sankyo Company, Limited | 動脈硬化及び高血圧症の予防及び治療のための医薬 |
JP2006298764A (ja) * | 2005-04-15 | 2006-11-02 | Sankyo Co Ltd | 高血圧症治療に有用な複合体 |
WO2007001067A2 (en) * | 2005-06-27 | 2007-01-04 | Daiichi Sankyo Company, Limited | Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker |
Non-Patent Citations (2)
Title |
---|
MATSUMOTO M.: "Yakuzaigaku Manual", vol. 1ST ED., 1989, NANZANDO CO., LTD., HAKKO, pages: 114 * |
OKANO T.: "Shin.Yakuzaigaku Soron", vol. 3RD ED., 1987, NANOKODO CO., LTD., HAKKO, pages: 134 - 145 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010107081A1 (ja) * | 2009-03-19 | 2010-09-23 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
JPWO2010107081A1 (ja) * | 2009-03-19 | 2012-09-20 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
JP6081058B2 (ja) * | 2009-03-19 | 2017-02-15 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
JP2011225537A (ja) * | 2010-03-31 | 2011-11-10 | Daiichi Sankyo Co Ltd | 固形製剤の製造方法 |
JP2015511635A (ja) * | 2012-03-30 | 2015-04-20 | デウン ファーマシューティカル カンパニー リミテッド | オルメサルタンメドキソミルとロスバスタチンまたはその塩とを含む医薬組成物 |
JP2014224099A (ja) * | 2013-04-15 | 2014-12-04 | 株式会社三和化学研究所 | オルメサルタンメドキソミルを含有する医薬組成物 |
Also Published As
Publication number | Publication date |
---|---|
KR20090094285A (ko) | 2009-09-04 |
TWI488658B (zh) | 2015-06-21 |
TW200835525A (en) | 2008-09-01 |
JP5241512B2 (ja) | 2013-07-17 |
JPWO2008078729A1 (ja) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009240389A8 (en) | Nanoemulsions for treating fungal, yeast and mold infections | |
MX285041B (es) | Composiciones de combustible que contienen farnesano y derivados de farnesano y metodo de preparacion y uso de estas. | |
WO2008005705A3 (en) | Metal-containing formulations and methods of use | |
HK1127282A1 (en) | Solid dosage form of olmesartan medoxomil and amlodipine | |
PL2044076T3 (pl) | Sposób wytwarzania asenapiny i związki pośrednie do stosowania w tym sposobie | |
WO2008027600A3 (en) | Imatinib compositions | |
IL207792A0 (en) | Methods, dosage forms, and kits for administering ziprasidone without food | |
EP1993322A4 (en) | ULTRASOUND SENSOR, AND METHOD OF MANUFACTURING SAME | |
GB0611443D0 (en) | Improvements in, or relating to, particle cassettes | |
WO2008078726A1 (ja) | 固形製剤 | |
HK1093288A2 (en) | Fibranchor, manufacture method and application method | |
WO2010069335A3 (en) | Diagnosis of endometritis | |
WO2008078729A1 (ja) | 溶出性改善方法 | |
WO2008021135A8 (en) | Syneretic composition, associated method and article | |
WO2007099555A3 (en) | Pharmaceutical tablet compositions containing irbesartan | |
GB2435262B (en) | Method, composition and articles | |
WO2007098924A3 (de) | Zusammensetzung umfassend ein mittel zum stabilisieren von wirkstoffen im trinkwasser und eine brausemischung, verfahren zu deren herstellung und deren verwendung | |
WO2009113091A3 (en) | Pharmaceutical compositions comprising valsartan | |
EP2048134A4 (en) | MEPTAZINOL DERIVATIVES WITH TWO LIGANDS AND / OR THEIR SALTS, PROCESS FOR PREPARING THEM AND APPLICATIONS THEREOF | |
WO2008078727A1 (ja) | 溶出性の改善された医薬組成物 | |
WO2008073317A3 (en) | Cytarabine for treatment of glioma | |
IL194689A0 (en) | Agent, composition and method | |
BRPI0818783A2 (pt) | Método de preparação de (6r)-3-hexil-4-hidróxi-6-undecil-5,6-diidropirano-2-ona, e intermediário empregado no método | |
WO2008074461A3 (de) | Fluoreszenz-nanopartikel | |
EP2042531A4 (en) | COPOLYMER SEQUENCE, COMPOSITION FOR RESIN MODIFICATION AND MODIFIED RESIN COMPOSITION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07860013 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008551107 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097012652 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07860013 Country of ref document: EP Kind code of ref document: A1 |